H. Conjeevaram

发表

NAFLD may be a common underlying liver disease in patients with hepatocellular Carcinoma in the United States

J. Marrero, R. Fontana, G. Su, 2002, Hepatology.

Metabolic Syndrome Is Associated with Greater Histologic Severity, Higher Carbohydrate, and Lower Fat Diet in Patients with NAFLD

H. Conjeevaram, H. Kang, J. Greenson, 2006, The American Journal of Gastroenterology.

CD73 (ecto‐5′‐nucleotidase) hepatocyte levels differ across mouse strains and contribute to mallory‐denk body formation

H. Conjeevaram, A. Lok, M. Omary, 2013, Hepatology.

Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma.

J. Marrero, R. Fontana, G. Su, 2005, Journal of hepatology.

Hepatic fat fraction: MR imaging for quantitative measurement and display--early experience.

H. Hussain, S. Adusumilli, T. Chenevert, 2005, Radiology.

Clinical and histopathologic features of fluoroquinolone-induced liver injury.

H. Conjeevaram, J. Rochon, J. Freston, 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C

J. Kalbfleisch, J. Marrero, R. Fontana, 2003, Hepatology.

Volunteer Blood Donors with Antibody to Hepatitis C Virus: Clinical, Biochemical, Virologic, and Histologic Features

H. Conjeevaram, D. Kleiner, P. Hayashi, 1995, Annals of Internal Medicine.

Virologic response and resistance to adefovir in patients with chronic hepatitis B.

J. Marrero, R. Fontana, H. Conjeevaram, 2006, Journal of hepatology.

Chapter 39 – Hepatitis B and C in Non–Liver Transplant Patients

H. Conjeevaram, A. Lok, 2012 .

Animal models of hepatic encephalopathy and hyperammonemia.

H. Conjeevaram, K. Mullen, R. Gacad, 1994, Advances in experimental medicine and biology.

Spectrum of disease associated with partial lipodystrophy: lessons from a trial cohort

Graham F. Brady, T. Chenevert, H. Conjeevaram, 2017, Clinical endocrinology.

Non-alcoholic fatty liver disease in diabetes: When to refer to the hepatologist?

H. Conjeevaram, A. Dassanayake, S. Singh, 2021, World journal of diabetes.

Expression of transforming growth factor alpha in the liver before and after interferon alfa therapy for chronic hepatitis B.

H. Conjeevaram, D. Kleiner, A. Bisceglie, 1995 .

Ribavirin as Therapy for Chronic Hepatitis C

H. Conjeevaram, J. Hoofnagle, C. Yurdaydın, 1995, Annals of Internal Medicine.

Continued progress against hepatitis C infection.

H. Conjeevaram, 2015, JAMA.

Impact of chronic hepatitis B and interferon‐α therapy on growth of children

J. Sarles, H. Conjeevaram, F. Alvarez, 2001 .

Impact of chronic hepatitis B and interferon-alpha therapy on growth of children.

J. Sarles, P. Rosenthal, H. Conjeevaram, 2001, Journal of viral hepatitis.

Metreleptin therapy for nonalcoholic steatohepatitis: Open-label therapy interventions in two different clinical settings.

C. Mantzoros, H. Hussain, T. Chenevert, 2021, Med.

A phase 2, randomized, double‐blind, placebo‐controlled study of GS‐9450 in subjects with nonalcoholic steatohepatitis

R. Levine, H. Conjeevaram, N. Chalasani, 2012, Hepatology.

Des‐gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients

J. Marrero, R. Fontana, G. Su, 2003, Hepatology.

Preservation of Portal Pressure Improves Growth and Metabolic Profile in the Male Portacaval-Shunted Rat

H. Conjeevaram, A. McCullough, K. Mullen, 2002, Digestive Diseases and Sciences.

Donor liver uridine diphosphate (UDP)-glucuronosyltransferase-1A1 deficiency causing Gilbert's syndrome in liver transplant recipients.

H. Conjeevaram, T. Schiano, H. Te, 2000, Transplantation.

Hepatic effects of long-term methotrexate use in the treatment of inflammatory bowel disease

H. Conjeevaram, S. Hanauer, T. Schiano, 2000, American Journal of Gastroenterology.

Gastric and duodenal ischaemia after transarterial chemoembolisation for hepatocellular carcinoma: an unexpected but significant complication

H. Conjeevaram, Arpan Patel, S. Chintalapati, 2018, BMJ Case Reports.

Reply:

J. Marrero, R. Fontana, G. Su, 2005 .

The gut microbiome and nonalcoholic fatty liver disease

H. Conjeevaram, Brian A. Nadeau, 2017, Clinical liver disease.

Reversal of behavioral changes in rats subjected to portacaval shunt with oral neomycin therapy

H. Conjeevaram, A. McCullough, K. Mullen, 1994, Hepatology.

Gender‐dependent reduction of spontaneous motor activity and growth in rats subjected to portacaval shunt

H. Conjeevaram, A. McCullough, K. Mullen, 1994, Hepatology.

NAFLD may be a common underlying liver disease in patients with hepatocellular Carcinoma in the United States

J. Marrero, R. Fontana, G. Su, 2002 .

Long-term outcome of hepatitis B virus-related glomerulonephritis after therapy with interferon alfa.

H. Conjeevaram, J. Hoofnagle, M. Fried, 1995, Gastroenterology.

Non-alcoholic Fatty Liver Disease: Not Time for an Obituary Just Yet!

M. Petroni, G. Marchesini, H. Conjeevaram, 2020, Journal of hepatology.

A new era in the treatment of chronic hepatitis C infection

H. Conjeevaram, G. Chandy, D. Jothimani, 2013, Indian Journal of Gastroenterology.

Rapidly progressive liver injury and fatal alcoholic hepatitis occurring after liver transplantation in alcoholic patients.

H. Conjeevaram, T. Schiano, J. Millis, 1999, Transplantation.

Occult hepatitis B virus infection: A hidden menace?

H. Conjeevaram, A. Lok, 2001, Hepatology.

Etiology of Hepatitis C: A Reassessment

H. Conjeevaram, 1999, American Journal of Gastroenterology.

Interferon alfa therapy for chronic hepatitis B in children: a multinational randomized controlled trial.

J. Sarles, P. Rosenthal, H. Conjeevaram, 1998, Gastroenterology.

Liver transplantation at the University of Chicago.

H. Conjeevaram, J. Millis, D. Cronin, 1999, Clinical transplants.

Associations between serum lipids and hepatitis C antiviral treatment efficacy

H. Conjeevaram, S. Belle, A. Wahed, 2010, Hepatology.

Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B.

H. Conjeevaram, J. Hoofnagle, D. Kleiner, 1995, The New England journal of medicine.

Management of chronic hepatitis B.

H. Conjeevaram, A. Lok, 2003, Journal of hepatology.

Disease status and therapeutic end points in hepatitis B

H. Conjeevaram, 2005 .

Corrigendum to “Management of chronic hepatitis B” [J Hepatol 38 (2003) S90–S103)]

H. Conjeevaram, A. Lok, 2003 .

IS LAMIVUDINE BENEFICIAL IN HBSAG+ PATIENTS AWAITING LIVER TRANSPLANTATION? EXPERIENCE IN 182 NORTH AMERICAN PATIENTS.

R. Fontana, H. Conjeevaram, E. Keeffe, 1999 .

Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1.

H. Conjeevaram, J. Hoofnagle, D. Kleiner, 2006, Gastroenterology.

Intensive Interferon Therapy Does Not Increase Virological Response Rates in African Americans with Chronic Hepatitis C

H. Conjeevaram, R. Sterling, M. Shiffman, 2004, Digestive Diseases and Sciences.

Fulminant hepatic failure secondary to malignant melanoma: case report and review of the literature

H. Conjeevaram, T. Schiano, H. Te, 1999, American Journal of Gastroenterology.

Management of chronic viral hepatitis in children.

H. Conjeevaram, A. D. Di Bisceglie, Hari S. Conjeevaram, 1995, Journal of pediatric gastroenterology and nutrition.

Therapy for chronic hepatitis B: nucleoside analogues in adult and pediatric patients.

H. Conjeevaram, 1998, Acta gastro-enterologica Belgica.

Sustained virologic response to therapy of recurrent hepatitis C after liver transplantation is related to early virologic response and dose adherence

J. Marrero, R. Fontana, G. Su, 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Initial experience with the modified extracorporeal liver-assist device for patients with fulminant hepatic failure: system modifications and clinical impact

H. Conjeevaram, J. Millis, D. Cronin, 2002, Transplantation.

Ribavirin as therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial.

H. Conjeevaram, J. Hoofnagle, C. Yurdaydın, 1995, Annals of internal medicine.

Race, insulin resistance and hepatic steatosis in chronic hepatitis C

H. Conjeevaram, J. Hoofnagle, D. Kleiner, 2007, Hepatology.

Prolonged therapy of chronic hepatitis C with ribavirin

H. Conjeevaram, J. Hoofnagle, D. Kleiner, 1996, Journal of viral hepatitis.

Clinical course and management of inflammatory bowel disease after liver transplantation.

H. Conjeevaram, T. Schiano, J. Thistlethwaite, 1998, Transplantation.

Effects of Belapectin, an Inhibitor of Galectin-3, in Patients with Nonalcoholic Steatohepatitis With Cirrhosis And Portal Hypertension.

H. Conjeevaram, N. Chalasani, D. Rockey, 2019, Gastroenterology.

Successful combined liver-heart transplantation in adults: report of three patients and review of the literature.

H. Conjeevaram, T. Schiano, J. Millis, 1999, Transplantation.

Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the European Association for the Study of the Liver and the American Association for the Study of Liver Diseases.

J. Talwalkar, H. Conjeevaram, F. Zoulim, 2014, Journal of hepatology.

A multicenter, randomized trial of daily high-dose interferon-alfa 2b for the treatment of chronic hepatitis C: pretreatment stratification by viral burden and genotype

H. Conjeevaram, K. Reddy, R. Sterling, 2000, American Journal of Gastroenterology.

Resolution of chronic hepatitis B-associated autoimmune neutropenia with interferon-α therapy

H. Conjeevaram, J. Hoofnagle, A. Soza, 2003 .

Clinical and Histological Features of Idiosyncratic Acute Liver Injury Caused by Temozolomide

William M. Lee, H. Conjeevaram, D. Kleiner, 2013, Digestive Diseases and Sciences.

Cryptic but Deadly: A Serious Killer in Patients with Advanced Liver Disease that Should Not Be Missed

H. Conjeevaram, A. Likhitsup, J. Berinstein, 2017, Cureus.

Assessing the Validity of Self-Reported Medication Adherence in Hepatitis C Treatment

Scott R. Smith, H. Conjeevaram, A. Wahed, 2007, The Annals of pharmacotherapy.

44 – Gender-Specific Issues in Liver Diseases

H. Conjeevaram, 2004 .

Vitamin D receptor (VDR) polymorphisms and bone mineral density (BMD) in primary biliary cirrhosis

H. Conjeevaram, J. Hoofnagle, D. Herion, 1995 .

Prognosis of hepatocellular carcinoma: Comparison of 7 staging systems in an American cohort

J. Marrero, R. Fontana, G. Su, 2005, Hepatology.

Meta‐analysis: insulin sensitizers for the treatment of non‐alcoholic steatohepatitis

H. Conjeevaram, M. Rogers, A. Singal, 2010, Alimentary pharmacology & therapeutics.

Editorial: Exercise for NAFLD: Does Intensity Matter?

H. Conjeevaram, D. Tiniakos, 2011, The American Journal of Gastroenterology.

One-Year Intense Nutritional Counseling Results in Histological Improvement in Patients with Nonalcoholic Steatohepatitis: A Pilot Study

H. Conjeevaram, Dawn M. Emick, A. Lok, 2005, The American Journal of Gastroenterology.

Predictors of a sustained beneficial response to interferon alfa therapy in chronic hepatitis C

H. Conjeevaram, J. Hoofnagle, J. Everhart, 1995, Hepatology.

Changes in characteristics of hepatitis C patients seen in a liver centre in the United States during the last decade

R. Fontana, H. Conjeevaram, A. Lok, 2015, Journal of viral hepatitis.

Liver injury associated with kratom, a popular opioid-like product: Experience from the U.S. drug induced liver injury network and a review of the literature.

H. Barnhart, R. Fontana, H. Conjeevaram, 2020, Drug and Alcohol Dependence.

Effectiveness of Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis

J. Marrero, R. Fontana, G. Su, 2012, Cancer Epidemiology, Biomarkers & Prevention.

A Deeper Look at the Small Bowel: Training Pathways in Video Capsule Endoscopy and Device-Assisted Enteroscopy

H. Conjeevaram, S. Saini, Michael D. Rice, 2018, Digestive Diseases and Sciences.

Impact of obesity, hepatic steatosis, and insulin resistance on hepatitis C treatment outcomes

H. Conjeevaram, Hesham M. Elgouhari, 2008 .

Changes in insulin sensitivity and body weight during and after peginterferon and ribavirin therapy for hepatitis C.

H. Conjeevaram, J. Hoofnagle, J. Everhart, 2011, Gastroenterology.

Host Genetics, Steatosis and Insulin Resistance among African Americans and Caucasian Americans with Hepatitis C Virus Genotype-1 Infection

H. Conjeevaram, D. Kleiner, S. Belle, 2009, Intervirology.

A pilot study of interferon alfa and ribavirin combination in liver transplant recipients with recurrent hepatitis C

H. Conjeevaram, R. Gish, V. Balan, 2002, Hepatology.

Night blindness secondary to vitamin A deficiency in a patient with bile duct strictures after liver transplantation.

H. Conjeevaram, G. Fishman, S. Grover, 1998, Transplantation.

Pnpla3 Genotype Rather Than Race May Explain the Lower Prevalence of Hepatic Steatosis Despite Worse Metabolic Risk Factors in African American Patients with Chronic Hepatitis C (Chc)

K. Shianna, D. Goldstein, Qianqian Zhu, 2011 .

Reversal of behavioral changes in rats subjected to portacaval shunt with oral neomycin therapy

H. Conjeevaram, A. McCullough, K. Mullen, 1994, Hepatology.

Tacrolimus treatment of steroid-resistant rejection provides economic advantages compared with OKT3 therapy.

H. Conjeevaram, E. Woodle, J. Thistlethwaite, 1997, Transplantation proceedings.

Successful use of tacrolimus for initial rejection episodes after liver transplantation.

H. Conjeevaram, T. Schiano, E. Woodle, 1998, Transplantation proceedings.

Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study.

William M. Lee, Huiman X. Barnhart, Robert J. Fontana, 2015, Gastroenterology.

Effect of lifetime alcohol consumption on the histological severity of non‐alcoholic fatty liver disease

H. Conjeevaram, J. Greenson, Hellan K. Kwon, 2014, Liver international : official journal of the International Association for the Study of the Liver.

Long-term follow-up of liver transplant recipients undergoing cyclosporine withdrawal.

H. Conjeevaram, T. Schiano, H. Te, 2001, Transplantation proceedings.

A phase 2, randomized, double-blind, placebo-controlled study of GS-9450 in subjects with nonalcoholic steatohepatitis.

H. Conjeevaram, N. Chalasani, M. Chojkier, 2012 .

Serum lipids and their associations with viral levels and liver disease severity in a treatment‐naïve chronic hepatitis C type 1‐infected cohort

H. Conjeevaram, S. Belle, A. Wahed, 2011, Journal of viral hepatitis.

A phase 2, randomized, double‐blind, placebo‐controlled study of GS‐9450 in subjects with nonalcoholic steatohepatitis

H. Conjeevaram, N. Chalasani, M. Chojkier, 2012, Hepatology.

Modern immunosuppression.

H. Conjeevaram, J. Millis, D. Cronin, 2000, Clinics in liver disease.

Interferon alfa for treatment of pediatric chronic hepatitis B: A randomized controlled multicenter trial.

J. Sarles, P. Rosenthal, H. Conjeevaram, 1997 .